Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation

p53 activation prevents the proliferation of genetically unstable cells. Conversely, p53 antagonism by its transcriptional target, the E3 ubiquitin ligase MDM2, is critical for the viability of unstressed, cycling cells. We demonstrate that MDM2 induces the degradation of p53 in both the nucleus and the cytoplasm. As p53 and MDM2 accumulate in the nuclei of stressed cells, we investigated mechanisms enabling p53 activation despite the high MDM2 levels generated during a DNA‐damage response. We show that DNA damage destabilized MDM2 by a mechanism involving damage‐activated kinases and MDM2 auto‐ubiquitination. p53 was stable and transcriptionally active when MDM2 was unstable, but became unstable and inactive as the damage response waned and MDM2 stabilized. Importantly, blocking MDM2 destabilization in DNA‐damaged cells prevented p53 target gene activation. Our data reveal that controlled MDM2 degradation is an important new step in p53 regulation.

[1]  Charles J. Sherr,et al.  The INK4a/ARF network in tumour suppression , 2001, Nature Reviews Molecular Cell Biology.

[2]  A. Levine,et al.  Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6 , 1998, Molecular and Cellular Biology.

[3]  C. Maki,et al.  The MDM2 RING-finger domain is required to promote p53 nuclear export , 2000, Nature Cell Biology.

[4]  M. E. Perry,et al.  mdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing Irradiation , 2003, Molecular and Cellular Biology.

[5]  K. Sakaguchi,et al.  Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like Kinase , 2000, The Journal of Biological Chemistry.

[6]  E. Appella,et al.  Mutation of Mouse p53 Ser23 and the Response to DNA Damage , 2002, Molecular and Cellular Biology.

[7]  T. Greiner,et al.  Mdm2 haplo‐insufficiency profoundly inhibits Myc‐induced lymphomagenesis , 2003, The EMBO journal.

[8]  J. Blaydes,et al.  The proliferation of normal human fibroblasts is dependent upon negative regulation of p53 function by mdm2 , 1998, Oncogene.

[9]  M. Yanagida,et al.  Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. , 1998, Experimental cell research.

[10]  D. Erdmann,et al.  Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1 , 2000, Oncogene.

[11]  B. Vojtesek,et al.  Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. , 1999, The Biochemical journal.

[12]  M. Dai,et al.  MDM2 Inhibits PCAF (p300/CREB-binding Protein-associated Factor)-mediated p53 Acetylation* , 2002, The Journal of Biological Chemistry.

[13]  C. Maki.  Oligomerization Is Required for p53 to be Efficiently Ubiquitinated by MDM2* , 1999, The Journal of Biological Chemistry.

[14]  Y. Xiong.  Faculty Opinions recommendation of p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo. , 2002 .

[15]  Bert Vogelstein,et al.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.

[16]  M. Kastan,et al.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.

[17]  U. Moll,et al.  Nuclear degradation of p53 occurs during down‐regulation of the p53 response after DNA damage , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  K. Tsai,et al.  An intact HDM2 RING-finger domain is required for nuclear exclusion of p53 , 2000, Nature Cell Biology.

[19]  Antony M. Carr,et al.  The evolution of diverse biological responses to DNA damage: insights from yeast and p53 , 2001, Nature Cell Biology.

[20]  G. Wahl,et al.  c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. , 2002, Molecular cell.

[21]  D. Keller,et al.  MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Lawrence A. Donehower,et al.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.

[23]  D. Lane,et al.  Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. , 2001, Experimental cell research.

[24]  R. Honda,et al.  Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase , 2000, Oncogene.

[25]  E. Stavridi,et al.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Sarkaria,et al.  Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. , 1998, Cancer research.

[27]  E. Lane,et al.  An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs. , 1999, Experimental cell research.

[28]  K. Vousden,et al.  Stress Signals Utilize Multiple Pathways To Stabilize p53 , 2000, Molecular and Cellular Biology.

[29]  A. Fersht,et al.  Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain , 1998, The EMBO journal.

[30]  D. Lane,et al.  Nuclear export inhibitor leptomycin B induces the appearance of novel forms of human Mdm2 protein , 2003, British Journal of Cancer.

[31]  B. Henderson,et al.  A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. , 2000, Experimental cell research.

[32]  D. Woods,et al.  Phosphorylation of HDM2 by Akt , 2002, Oncogene.

[33]  M. Oren,et al.  The p53-Mdm2 module and the ubiquitin system. , 2003, Seminars in cancer biology.

[34]  Shengyun Fang,et al.  Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53* , 2000, The Journal of Biological Chemistry.

[35]  P. Herrlich,et al.  DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation , 1999, Oncogene.

[36]  H. Kawai,et al.  Mutual Dependence of MDM 2 and MDMX in Their Functional Inactivation of p 53 * , 2002 .

[37]  D. George,et al.  Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein* , 1999, The Journal of Biological Chemistry.

[38]  G. Wahl,et al.  A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking , 1999, The EMBO journal.

[39]  David P. Lane,et al.  Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo , 1997, Current Biology.

[40]  A. Giaccia,et al.  Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. , 1999, Cancer research.

[41]  J. Niland,et al.  The MDM2 gene amplification database. , 1998, Nucleic acids research.

[42]  M. Oren,et al.  p53 Activation by Nitric Oxide Involves Down-regulation of Mdm2* , 2002, The Journal of Biological Chemistry.

[43]  A. Levine,et al.  Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. , 1994, Genes & development.

[44]  Yoichi Taya,et al.  Regulation of p53 by Hypoxia: Dissociation of Transcriptional Repression and Apoptosis from p53-Dependent Transactivation , 2001, Molecular and Cellular Biology.

[45]  E. Appella,et al.  Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.

[46]  A. Jochemsen,et al.  Mutual Dependence of MDM2 and MDMX in Their Functional Inactivation of p53* , 2002, The Journal of Biological Chemistry.

[47]  C. Maki,et al.  Downregulation of MDM2 stabilizes p53 by inhibiting p53 ubiquitination in response to specific alkylating agents , 2001, FEBS letters.

[48]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[49]  D. Woods,et al.  C-Terminal Ubiquitination of p53 Contributes to Nuclear Export , 2001, Molecular and Cellular Biology.

[50]  M. Kubbutat,et al.  Regulation of p53 Function and Stability by Phosphorylation , 1999, Molecular and Cellular Biology.

[51]  L. Povirk,et al.  DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enediynes. , 1996, Mutation research.

[52]  Guillermina Lozano,et al.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 , 1995, Nature.

[53]  T. van Dyke,et al.  p19ARF Is Dispensable for Oncogenic Stress-Induced p53-Mediated Apoptosis and Tumor Suppression In Vivo , 2002, Molecular and Cellular Biology.

[54]  Yanping Zhang,et al.  Nucleocytoplasmic Shuttling of p53 Is Essential for MDM2-Mediated Cytoplasmic Degradation but Not Ubiquitination , 2003, Molecular and Cellular Biology.

[55]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.